SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Regulatory & Safety: Top Headlines

Update

Pfizer considers splitting company or going after M&A

Pfizer may continue pursuing M&As or break up its businesses (Image: Ben Frost)

27-Jan-2015 - Pfizer says it is considering breaking up the company in 2015, or alternatively continuing its pursuit of a major acquisition.

Related news

News in brief

US Senator proposes NIH to be funded through Big Pharma ‘swear jar’

26-Jan-2015 - Pharma firms that break the law could be fined one percent of their blockbuster drug revenues if proposed US legislation is introduced.

News in brief

30 months for smuggler of Roche cancer drugs which lacked API

26-Jan-2015 - A second man has received a prison sentence after counterfeit vials of a Roche cancer drug containing no API were seized in 2012.

People on the Move

CEOs found for BSM and Repligen

26-Jan-2015 - Plus WHO appoints AIDS pioneer as tuberculosis expert, and Amgen director to lead ABPI innovation.

Syrzia win may land pharma with more Greek debts, analyst

26-Jan-2015 - Syriza's election victory may prompt drugmakers already burdened with unpaid Greek bills to rethink their presence in the country according to one analyst.  

FDA's wearables guidance could slow pharma adoption in short-term, says analyst

22-Jan-2015 - Draft guidance distinguishing wearable medical devices from ‘general wellness’ devices could slow pharma’s adoption of such data in the short-term, according to an analyst.

Antibiotics "a terrible business model" for Pharmas expert tells Davos

22-Jan-2015 - Drug industry execs  at the World Economic Forum in Davos were told they are no longer best placed to develop antibiotics by a panel who said Governments should lead efforts to create these vital new drugs.

State of the Union: Obama’s fast-track trade plans divide pharma

22-Jan-2015 - President Obama in his State of the Union address has called for the power to personally make stronger trade agreements – bringing divisive EU deal TTIP closer to adoption and angering campaigners for drugs access.

Regulatory & Safety: Featured news

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social...

Resistance is…years away: New compound could delay post antibiotic era

Resistance is…years away: New compound could delay post antibiotic era

Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape...

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk...

Gilead strikes back at AbbVie with exclusive payer deal for hep C drug

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of...

Not prepared for track & trace? US FDA grants amnesty until May

Not prepared for track & trace? US FDA grants amnesty until May

The US FDA will give drugmakers and distributors until May to comply with new track and trace...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...